Current Pathobiology Reports

, Volume 6, Issue 4, pp 241–246 | Cite as

Perioperative Developments in Biliary Atresia Treatment

  • O. Madadi-SanjaniEmail author
  • C. Petersen
Pathobiology of Orphan Diseases (S Ranganathan, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Pathobiology of Orphan Diseases


Purpose of Review

This paper presents an overview of the current developments in the perioperative biliary atresia (BA) treatment.

Recent Findings

Biliary atresia is a rare cholangiopathy and the most common indication for pediatric liver transplantation. Kasai portoenterostomy is the primary therapy, leading to sufficient biliary drainage in 20–30% of patients with native liver. Multiple strategies in preoperative, operative, and postoperative care were tested to improve survival with native liver (SNL). Screening methods, centralization of care to specialized centers, laparoscopic Kasai procedure, and adjuvant steroid therapies are suggested to improve the operative outcomes.


There is no evident superiority of laparoscopic KPE nor adjuvant steroid therapy. However, screening programs and centralization of care to specialized centers are endorsed.


Biliary atresia Kasai portoenterostomy Screening Centralization Laparoscopic Kasai 



Biliary atresia


Biliary atresia and related disorders


Childhood Liver Disease Research and Education Network


European Reference Networks


Jaundice-free survival with native liver


Kasai portoenterostomy


Survival with native liver


Steroids in Biliary Atresia Randomized Trial


Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Petersen C, Davenport M. Aetiology of biliary atresia: what is actually known? Orphanet J Rare Dis. 2013;8:128.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Asai A, Miethke A, Bezerra JA. Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes. Nat Rev Gastroenterol Hepatol. 2015;12:342–52.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    •• Davenport M, et al. Biliary atresia in England and Wales: results of centralization and new benchmark. J Pediatr Surg. 2011;46:1689–94 This study presents the benefits of centralization of BA treatment in England and Wales for the postoperative outcomes. CrossRefPubMedGoogle Scholar
  4. 4.
    •• Chardot C, et al. Improving outcomes of biliary atresia: French national series 1986–2009. J Hepatol. 2013;58:1209–17 This study presents the results of decentralized, institutional collaborations for BA treatment. CrossRefPubMedGoogle Scholar
  5. 5.
    de Vries W, et al. Biliary atresia in the Netherlands: outcome of patients diagnosed between 1987 and 2008. J Pediatr. 2012;160:638–644.e2.CrossRefPubMedGoogle Scholar
  6. 6.
    Stagg H, et al. Variability of diagnostic approach, surgical technique, and medical management for children with biliary atresia in Canada - is it time for standardization. J Pediatr Surg. 2017;52:802–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Davenport M. Adjuvant therapy in biliary atresia: hopelessly optimistic or potential for change? Pediatr Surg Int. 2017;33:1263–73.CrossRefPubMedGoogle Scholar
  8. 8.
    Shneider BL, et al. Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia. Pediatrics. 2012;130:e607–14.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Zhang M-Z, Xun P-C, He K, Cai W. Adjuvant steroid treatment following Kasai portoenterostomy and clinical outcomes of biliary atresia patients: an updated meta-analysis. World J Pediatr WJP. 2017;13:20–6.CrossRefPubMedGoogle Scholar
  10. 10.
    Lampela H, et al. National centralization of biliary atresia care to an assigned multidisciplinary team provides high-quality outcomes. Scand J Gastroenterol. 2012;47:99–107.CrossRefPubMedGoogle Scholar
  11. 11.
    Klemann C, et al. Interleukin 17, produced by γδ T cells, contributes to hepatic inflammation in a mouse model of biliary atresia and is increased in livers of patients. Gastroenterology. 2016;150:229–241.e5.CrossRefPubMedGoogle Scholar
  12. 12.
    Petersen C. Biliary atresia: the animal models. Semin Pediatr Surg. 2012;21:185–91.CrossRefPubMedGoogle Scholar
  13. 13.
    Petersen C, et al. New aspects in a murine model for extrahepatic biliary atresia. J Pediatr Surg. 1997;32:1190–5.CrossRefPubMedGoogle Scholar
  14. 14.
    Nio M, Wada M, Sasaki H, Tanaka H. Effects of age at Kasai portoenterostomy on the surgical outcome: a review of the literature. Surg Today. 2015;45:813–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Wildhaber BE, et al. Biliary atresia: Swiss national study, 1994-2004. J Pediatr Gastroenterol Nutr. 2008;46:299–307.CrossRefPubMedGoogle Scholar
  16. 16.
    Leonhardt J, et al. Biliary atresia: lessons learned from the voluntary German registry. Eur J Pediatr Surg Off J Austrian Assoc Pediatr Surg Al Z Für Kinderchir. 2011;21:82–7.Google Scholar
  17. 17.
    • Gu Y-H, et al. Stool color card screening for early detection of biliary atresia and long-term native liver survival: a 19-year cohort study in Japan. J Pediatr. 2015;166:897–902.e1 This study presents the improvement of KPE outcomes after initiation of a nationwide screening program in Japan. CrossRefPubMedGoogle Scholar
  18. 18.
    Lien T-H, et al. Effects of the infant stool color card screening program on 5-year outcome of biliary atresia in Taiwan. Hepatolology. 2011;53:202–8.CrossRefGoogle Scholar
  19. 19.
    Chen S-M, et al. Screening for biliary atresia by infant stool color card in Taiwan. Pediatrics. 2006;117:1147–54.CrossRefPubMedGoogle Scholar
  20. 20.
    Hsiao C-H, et al. Universal screening for biliary atresia using an infant stool color card in Taiwan. Hepatology. 2008;47:1233–40.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Lin J-S, et al. Reduction of the ages at diagnosis and operation of biliary atresia in Taiwan: a 15-year population-based cohort study. World J Gastroenterol. 2015;21:13080–6.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Wildhaber BE. Screening for biliary atresia: Swiss stool color card. Hepatology. 2011;54:367–8; author reply 369.CrossRefPubMedGoogle Scholar
  23. 23.
    Borgeat M, Korff S, Wildhaber BE. Newborn biliary atresia screening with the stool colour card: a questionnaire survey of parents. BMJ Paediatr Open. 2018;2:e000269.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Woolfson JP, et al. Province-wide biliary atresia home screening program in British Columbia: evaluation of first 2 years. J Pediatr Gastroenterol Nutr. 2018;66:845–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Schreiber RA, et al. Home-based screening for biliary atresia using infant stool colour cards: a large-scale prospective cohort study and cost-effectiveness analysis. J Med Screen. 2014;21:126–32.CrossRefPubMedGoogle Scholar
  26. 26.
    Mogul D, Zhou M, Intihar P, Schwarz K, Frick K. Cost-effective analysis of screening for biliary atresia with the stool color card. J Pediatr Gastroenterol Nutr. 2015;60:91–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Kong Y-Y, et al. Modified stool color card with digital images was efficient and feasible for early detection of biliary atresia-a pilot study in Beijing, China. World J Pediatr WJP. 2016;12:415–20.CrossRefPubMedGoogle Scholar
  28. 28.
    Hoshino E, et al. An iPhone application using a novel stool color detection algorithm for biliary atresia screening. Pediatr Surg Int. 2017;33:1115–21.CrossRefPubMedGoogle Scholar
  29. 29.
    Harpavat S, Garcia-Prats JA, Shneider BL. Newborn bilirubin screening for biliary atresia. N Engl J Med. 2016;375:605–6.CrossRefPubMedGoogle Scholar
  30. 30.
    Harpavat S, et al. Newborn direct or conjugated bilirubin measurements as a potential screen for biliary atresia. J Pediatr Gastroenterol Nutr. 2016;62:799–803.CrossRefPubMedGoogle Scholar
  31. 31.
    Stringer MD. Biliary atresia: service delivery and outcomes. Semin Pediatr Surg. 2008;17:116–22.CrossRefPubMedGoogle Scholar
  32. 32.
    Hukkinen M, et al. Treatment policy and liver histopathology predict biliary atresia outcomes: results after National Centralization and Protocol Biopsies. J Am Coll Surg. 2018;226:46–57.e1.CrossRefPubMedGoogle Scholar
  33. 33.
    • Leonhardt J, et al. Biliary atresia: lessons learned from the voluntary German registry. Eur J Pediatr Surg Off J Austrian Assoc Pediatr Surg Al Z Kinderchir. 2011;21:82–7 This study discusses the problems of voluntary registries for rare diseases. Google Scholar
  34. 34.
    Héon-Klin V. European Reference Networks for rare diseases: what is the conceptual framework? Orphanet J Rare Dis. 2017;12:137.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Morciano C, Laricchiuta P, Taruscio D, Schünemann H. European Reference Networks and guideline development and use: challenges and opportunities. Public Health Genomics. 2015;18:318–20.CrossRefPubMedGoogle Scholar
  36. 36.
    Hashimoto T, et al. A modification of hepatic portoenterostomy (Kasai operation) for biliary atresia. J Am Coll Surg. 1997;185:548–53.CrossRefPubMedGoogle Scholar
  37. 37.
    Ramachandran P, et al. The extended Kasai portoenterostomy for biliary atresia: a preliminary report. J Indian Assoc Pediatr Surg. 2016;21:66–71.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Wada M, et al. Experience of treating biliary atresia with three types of portoenterostomy at a single institution: extended, modified Kasai, and laparoscopic modified Kasai. Pediatr Surg Int. 2014;30:863–70.CrossRefPubMedGoogle Scholar
  39. 39.
    Lishuang M, et al. Laparoscopic portoenterostomy versus open portoenterostomy for the treatment of biliary atresia: a systematic review and meta-analysis of comparative studies. Pediatr Surg Int. 2015;31:261–9.CrossRefPubMedGoogle Scholar
  40. 40.
    Hussain MH, Alizai N, Patel B. Outcomes of laparoscopic Kasai portoenterostomy for biliary atresia: a systematic review. J Pediatr Surg. 2017;52:264–7.CrossRefPubMedGoogle Scholar
  41. 41.
    •• Ure BM, et al. Survival with the native liver after laparoscopic versus conventional kasai portoenterostomy in infants with biliary atresia: a prospective trial. Ann Surg. 2011;253:826–30 This study presents a rare attempt of a prospective study to investigate the effectivity of laparoscopic Kasai procedure. The study had to be stopped due to the significantly higher rate of liver transplantations in the laparoscopic cohort. CrossRefPubMedGoogle Scholar
  42. 42.
    Huang S-Y, Yeh C-M, Chen H-C, Chou C-M. Reconsideration of laparoscopic Kasai operation for biliary atresia. J Laparoendosc Adv Surg Tech A. 2018;28:229–34.CrossRefPubMedGoogle Scholar
  43. 43.
    Li Y, et al. Medium-term outcome of laparoscopic Kasai portoenterostomy for biliary atresia with 49 cases. J Pediatr Gastroenterol Nutr. 2018;66:857–60.CrossRefPubMedGoogle Scholar
  44. 44.
    Cazares J, et al. Laparoscopic portoenterostomy for biliary atresia: single-center experience and review of literatures. Pediatr Surg Int. 2017;33:1341–54.CrossRefPubMedGoogle Scholar
  45. 45.
    Li Z, Ye Y, Wu Z, Wang B. Learning curve analysis of laparoscopic Kasai portoenterostomy. J Laparoendosc Adv Surg Tech A. 2017;27:979–82.CrossRefPubMedGoogle Scholar
  46. 46.
    Nakamura H, et al. Does the level of transection of the biliary remnant affect outcome after laparoscopic Kasai portoenterostomy for biliary atresia? J Laparoendosc Adv Surg Tech A. 2017.
  47. 47.
    Meyers RL, et al. High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. J Pediatr Surg. 2003;38:406–11.CrossRefGoogle Scholar
  48. 48.
    Stringer MD, Davison SM, Rajwal SR, McClean P. Kasai portoenterostomy: 12-year experience with a novel adjuvant therapy regimen. J Pediatr Surg. 2007;42:1324–8.CrossRefPubMedGoogle Scholar
  49. 49.
    Shimadera S, et al. The significance of steroid therapy after hepatoportoenterostomy in infants with biliary atresia. Eur J Pediatr Surg Off J Austrian Assoc Pediatr Surg Al Z Kinderchir. 2007;17:100–3.Google Scholar
  50. 50.
    Kobayashi H, et al. Optimum prednisolone usage in patients with biliary atresia postportoenterostomy. J Pediatr Surg. 2005;40:327–30.CrossRefPubMedGoogle Scholar
  51. 51.
    Escobar MA, et al. Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg. 2006;41:99–103; discussion 99–103.CrossRefPubMedGoogle Scholar
  52. 52.
    Davenport M, et al. Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology. 2007;46:1821–7.CrossRefPubMedGoogle Scholar
  53. 53.
    Davenport M, Parsons C, Tizzard S, Hadzic N. Steroids in biliary atresia: single surgeon, single centre, prospective study. J Hepatol. 2013;59:1054–8.CrossRefPubMedGoogle Scholar
  54. 54.
    Petersen C, et al. Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia. Am J Gastroenterol. 2008;103:712–9.CrossRefPubMedGoogle Scholar
  55. 55.
    Vejchapipat P, Passakonnirin R, Sookpotarom P, Chittmittrapap S, Poovorawan Y. High-dose steroids do not improve early outcome in biliary atresia. J Pediatr Surg. 2007;42:2102–5.CrossRefPubMedGoogle Scholar
  56. 56.
    Chung HY, Kak Yuen Wong K, Cheun Leung Lan L, Kwong Hang Tam P. Evaluation of a standardized protocol in the use of steroids after Kasai operation. Pediatr Surg Int. 2008;24:1001–4.CrossRefPubMedGoogle Scholar
  57. 57.
    Sarkhy A, Schreiber RA, Milner RA, Barker CC. Does adjuvant steroid therapy post-Kasai portoenterostomy improve outcome of biliary atresia? Systematic review and meta-analysis. Can J Gastroenterol J Can Gastroenterol. 2011;25:440–4.CrossRefGoogle Scholar
  58. 58.
    Zhang D, et al. Postoperative steroids after Kasai portoenterostomy for biliary atresia: a meta-analysis. Int J Surg Lond Engl. 2014;12:1203–9.CrossRefGoogle Scholar
  59. 59.
    Japanese Biliary Atresia Society, Nio M, Muraji T. Multicenter randomized trial of postoperative corticosteroid therapy for biliary atresia. Pediatr Surg Int. 2013;29:1091–5.CrossRefGoogle Scholar
  60. 60.
    •• Bezerra JA, et al. Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. JAMA. 2014;311:1750–9 The authors in this study investigated the effect of adjuvant corticosteroids following Kasai procedure on the postoperative outcome in a prospective, randomized trial, showing no significant benefits of treatment. CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Goodhue C, Fenlon M, Wang KS. Newborn screening for biliary atresia in the United States. Pediatr Surg Int. 2017;33:1315–8.CrossRefPubMedGoogle Scholar
  62. 62.
    Redkar R, et al. Outcome of biliary atresia after Kasai’s portoenterostomy: a 15-year experience. Indian Pediatr. 2017;54:291–4.CrossRefPubMedGoogle Scholar
  63. 63.
    Nio M, Wada M, Sasaki H, Tanaka H, Watanabe T. Long-term outcomes of biliary atresia with splenic malformation. J Pediatr Surg. 2015;50:2124–7.CrossRefPubMedGoogle Scholar
  64. 64.
    Ng VL, et al. Medical status of 219 children with biliary atresia surviving long-term with their native livers: results from a North American multicenter consortium. J Pediatr. 2014;165:539–546.e2.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Chan KWE, et al. Laparoscopic versus open Kasai portoenterostomy in infant with biliary atresia: a retrospective review on the 5-year native liver survival. Pediatr Surg Int. 2012;28:1109–13.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Center of Pediatric SurgeryHannover Medical SchoolHannoverGermany

Personalised recommendations